Co-Authors
This is a "connection" page, showing publications co-authored by Ichiro Takeuchi and Tomoki Nakagawa.
Connection Strength
0.700
-
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J. 2021 Aug 16; 19(1):55.
Score: 0.241
-
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study. Thromb J. 2021 Apr 20; 19(1):26.
Score: 0.235
-
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J Infect. 2021 02; 82(2):282-327.
Score: 0.225